Feedback / Questions
tuxobertinib (BDTX-189) - Black Diamond Therap
BDTX-4933 - Black Diamond Therap
Undisclosed FGFR inhibitor - Black Diamond Therap
BDTX-1535 - Black Diamond Therap
https://www.globenewswire.com/news-release/2022/04/25/2428231/0/en/Black-Diamond-Therapeutics-Announces-Pipeline-Prioritization-and-Workforce-Realignment.html
Apr 25, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next